Wang Ying, Zhang Yang, Yu Qian, Zhu Kun
Department of Pharmacy, The Third Hospital of Jilin University, Jilin University, Changchun, China.
School of Biology and Food Engineering, Changshu Institute of Technology, Changshu, China.
Front Pharmacol. 2020 Jun 24;11:966. doi: 10.3389/fphar.2020.00966. eCollection 2020.
Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-19 diagnosis and treatment. This can provide a reference for other medical institutions on rational drug use and pharmaceutical care for severe COVID-19 patients.
鉴于由新型冠状病毒肺炎（COVID-19）引发的当前大流行的极端重要性，且由于科学家们一致认为尚无已确定的治疗方法，本文依据当前COVID-19诊断和治疗指南，详细分析了一名重症COVID-19患者使用康复期血浆和药物的治疗情况。这可为其他医疗机构对重症COVID-19患者合理用药及药学服务提供参考。
